Genzyme Receives Complete Response, Warning Letters For Lumizyme

Despite receiving a “complete response” letter and manufacturing warning letter on the same day, Genzyme remains upbeat about the likelihood of approval for its 2,000L scale-up of Myozyme.

More from Archive

More from Pink Sheet